B2V168 AF NFT

ATP-dependent dethiobiotin synthetase BioD

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieh7ii52exf2g2bsy5j74ahipifxuz7japg5nl6bylt26cgz5awqu/metadata.json
IPFS of structure file: 
bafybeibms23hi4ngfqefq3dk5bcrlfs2bksj4twlutd6nhl3nruzejep54/AF-B2V168-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x661f92Fc5950020C7aB410B5F5b9a3f429F49Ae5
First NFT owner address (bech32): 
genesis1vc0e9lze2qpqc745zz6ltwdr7s5lfxh9yetntg
Current NFT ID #43988 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
43988
Accession (UniProt):
B2V168
Name::
ATP-dependent dethiobiotin synthetase BioD
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V168 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V168|BIOD_CLOBA ATP-dependent dethiobiotin synthetase BioD OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=bioD PE=3 SV=1 MAKGVFITATNTDIGKTYITALIVKKLREANINCGYYKAVLSGAEIINNNIVAGDAKYVYNVANIKGNPNKCVSYIFEQPVSPHLAAKLNNVHISMDKIVDDFNYICNEHDYITVEGSGGIVCPIYYDKEKIMLTDIIKKLKIPIILVSSSGLGSINGTILTLEYIKKHNITVNSIILNNYDKNNIIHIDNRIILEEMTNLPVYICEQYSKDIDIPLKELKQFYDFI